WAVE LIFE SCIENCES LTD. Increase (Decrease) in Other Operating Assets
WAVE LIFE SCIENCES LTD. (WVE) reported Increase (Decrease) in Other Operating Assets of $1.47 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $722.00K, a 262.81% increase year-over-year.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $751.00K.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $452.00K, a 89.27% decline year-over-year.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$4.85M.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other operating assets for fiscal 2025 was -$4.31M, a 233.77% decline from fiscal 2024.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other operating assets for fiscal 2024 was $3.23M, a 60.45% increase from fiscal 2023.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other operating assets for fiscal 2023 was $2.01M.
- WAVE LIFE SCIENCES LTD. increase (decrease) in other operating assets for fiscal 2022 was -$3.39M, a 1104.14% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $722.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.47M 10-Q · filed 2026-07-30 | $1.93M derived: sum of 3 quarters · filed 2026-07-30 | -$2.92M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $751.00K 10-Q · filed 2026-04-28 | $1.20M derived: sum of 2 quarters · filed 2026-04-28 | -$3.64M derived: sum of 3 quarters · filed 2026-04-28 | -$3.44M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $452.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.39M derived: sum of 2 quarters · filed 2026-02-26 | -$4.20M derived: sum of 3 quarters · filed 2026-07-30 | -$4.31M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$4.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$4.65M derived: sum of 2 quarters · filed 2026-07-30 | -$4.77M 10-Q · filed 2025-11-10 | -$552.00K derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $81.00K 10-Q · filed 2026-07-30 | $4.29M derived: sum of 3 quarters · filed 2026-07-30 | $1.91M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | -$118.00K 10-Q · filed 2026-04-28 | $4.10M derived: sum of 2 quarters · filed 2026-04-28 | $1.71M derived: sum of 3 quarters · filed 2026-04-28 | $1.71M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-12-31 | $4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.82M derived: sum of 2 quarters · filed 2026-02-26 | $1.83M derived: sum of 3 quarters · filed 2026-02-26 | $3.23M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.38M derived: sum of 2 quarters · filed 2025-11-10 | -$989.00K 10-Q · filed 2025-11-10 | -$1.08M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $1.40M 10-Q · filed 2025-07-30 | $1.31M derived: sum of 3 quarters · filed 2026-02-26 | $1.04M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $1.39M 10-Q · filed 2025-05-08 | $1.30M derived: sum of 2 quarters · filed 2026-02-26 | $1.03M derived: sum of 3 quarters · filed 2026-02-26 | $1.60M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$363.00K derived: sum of 2 quarters · filed 2026-02-26 | $206.00K derived: sum of 3 quarters · filed 2026-02-26 | $2.01M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $297.00K derived: sum of 2 quarters · filed 2024-11-12 | $2.10M 10-Q · filed 2024-11-12 | $2.21M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2023-06-30 | $569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.37M 10-Q · filed 2024-08-08 | $2.48M derived: sum of 3 quarters · filed 2025-03-04 | -$2.97M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2023-03-31 | $1.80M 10-Q · filed 2024-05-10 | $1.91M derived: sum of 2 quarters · filed 2025-03-04 | -$3.54M derived: sum of 3 quarters · filed 2025-03-04 | -$2.44M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2022-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$5.34M derived: sum of 2 quarters · filed 2025-03-04 | -$4.25M derived: sum of 3 quarters · filed 2025-03-04 | -$3.39M 10-K · filed 2025-03-04 | |
| 2022-09-30 | -$5.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$4.35M derived: sum of 2 quarters · filed 2023-11-09 | -$3.50M 10-Q · filed 2023-11-09 | -$2.12M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.95M 10-Q · filed 2023-08-03 | $3.33M derived: sum of 3 quarters · filed 2023-08-03 | -$1.19M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $851.00K 10-Q · filed 2023-05-03 | $2.24M derived: sum of 2 quarters · filed 2023-05-03 | -$2.29M derived: sum of 3 quarters · filed 2023-05-03 | -$526.00K derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$3.14M derived: sum of 2 quarters · filed 2023-03-23 | -$1.38M derived: sum of 3 quarters · filed 2023-03-23 | $338.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.76M derived: sum of 2 quarters · filed 2022-11-10 | -$1.05M 10-Q · filed 2022-11-10 | -$62.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $3.48M 10-Q · filed 2022-08-11 | $4.46M derived: sum of 3 quarters · filed 2022-08-11 | -$10.80M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $1.72M 10-Q · filed 2022-05-12 | $2.70M derived: sum of 2 quarters · filed 2022-05-12 | -$12.56M derived: sum of 3 quarters · filed 2022-05-12 | -$14.39M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$14.27M derived: sum of 2 quarters · filed 2022-03-03 | -$16.10M derived: sum of 3 quarters · filed 2022-03-03 | -$14.12M 10-K · filed 2022-03-03 | |
| 2020-09-30 | -$15.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$17.09M derived: sum of 2 quarters · filed 2021-11-10 | -$15.11M 10-Q · filed 2021-11-10 | -$22.77M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $151.00K 10-Q · filed 2021-08-05 | -$7.52M derived: sum of 3 quarters · filed 2021-08-05 | $5.07M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $1.98M 10-Q · filed 2021-05-13 | -$5.69M derived: sum of 2 quarters · filed 2021-05-13 | $6.90M derived: sum of 3 quarters · filed 2021-05-13 | $8.23M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | -$7.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $4.92M derived: sum of 2 quarters · filed 2021-03-04 | $6.25M derived: sum of 3 quarters · filed 2021-03-04 | $8.37M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $12.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $13.91M derived: sum of 2 quarters · filed 2020-11-09 | $16.04M 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $3.45M 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $2.12M 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | $8.69M 10-K · filed 2020-03-02 | $52.00K 10-K · filed 2019-03-01 | |||
| 2017-12-31 | $2.43M 10-K · filed 2020-03-02 | $358.00K 10-K · filed 2019-03-01 | |||
| 2016-12-31 | $53.00K 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |